CAP and CLIA: The Regulatory Framework for North American Clinical Laboratories

An overview of CLIA — the US federal statute governing clinical laboratories — and CAP accreditation, the dominant voluntary quality program that provides CLIA deemed status. Includes the Canadian context and how these frameworks interact.

Clinical laboratories operating in North America encounter two distinct but interrelated regulatory frameworks: CLIA (Clinical Laboratory Improvement Amendments), a US federal statute that establishes minimum quality standards for all clinical laboratories in the United States, and CAP (College of American Pathologists) accreditation, a widely adopted voluntary program that provides deemed status under CLIA. Understanding the relationship between these frameworks — and how they interact with Canadian provincial regulation — is essential for laboratory directors, quality managers, and organizations that operate across the Canada-US border.

What is CLIA?

The Clinical Laboratory Improvement Amendments of 1988 (CLIA) established federal standards applicable to all US clinical laboratories that perform testing on human specimens for health assessment, or for the diagnosis, prevention, or treatment of disease. CLIA is administered by the Centers for Medicare & Medicaid Services (CMS) in coordination with the FDA and CDC. Under CLIA, every clinical laboratory in the United States must hold a certificate issued by CMS, meet defined quality and personnel standards appropriate to the complexity of tests performed, and participate in proficiency testing for regulated analytes.

CLIA certificate types

CLIA establishes a tiered certification structure based on the complexity of testing performed:

• Certificate of Waiver — issued to laboratories performing only FDA-cleared waived tests (simple, low-risk); requires only following manufacturer instructions and reporting to CMS
• Certificate for Provider-Performed Microscopy (PPM) — for specific microscopy examinations performed by physicians, midlevel providers, or dentists during patient visits
• Certificate of Registration — a transitional certificate issued while a laboratory awaits inspection or accreditation
• Certificate of Compliance — requires biennial on-site inspection by CMS or a CMS-designated state agency against CLIA standards
• Certificate of Accreditation — granted to laboratories accredited by a CMS-approved accreditation organization; provides deemed status exempting the laboratory from routine CMS inspections

CLIA personnel requirements

CLIA establishes minimum personnel qualifications for laboratory directors, technical supervisors, clinical consultants, and testing personnel, with requirements scaled to the complexity of testing. For high-complexity testing — which encompasses most clinical laboratory disciplines — the laboratory director must hold a MD, DO, or doctoral degree in a chemical, physical, biological, or clinical laboratory science, with appropriate training or experience. Testing personnel performing high-complexity testing must meet defined educational and experience requirements. CLIA personnel standards represent the minimum; CAP accreditation and ISO 15189 impose additional expectations in many cases.

CAP accreditation and deemed status

The College of American Pathologists (CAP) accreditation program is a voluntary quality program that CMS has recognized as providing deemed status under CLIA. A CAP-accredited laboratory is presumed to comply with applicable CLIA requirements and is generally exempt from routine CMS inspection cycles. This deemed status is one of the primary incentives driving CAP adoption, particularly among hospital-based and reference laboratories subject to both CMS oversight and hospital quality requirements.

CAP accreditation uses a discipline-organized checklist framework. Each laboratory specialty — chemistry, haematology, microbiology, blood bank, molecular pathology, anatomical pathology, transfusion medicine, and others — has its own checklist with requirements that frequently exceed CLIA minimums. CAP checklists are updated regularly, with new requirements introduced as clinical practice and technology evolve.

How CAP inspections work

CAP inspections are conducted by peer inspectors — credentialed laboratory professionals from other CAP-accredited laboratories who volunteer or are assigned as inspectors. Biennial on-site inspections are the standard cadence. An inspection team reviews documentation (policies, SOPs, personnel records, QC records, PT results, maintenance logs), observes laboratory processes, interviews technical staff and the laboratory director, and assesses compliance with applicable CAP checklists.

Deficiencies identified during inspection are classified as Phase I (requiring correction but not immediate action) or Phase II (requiring documented corrective action, evidence of resolution, and in some cases follow-up review before the inspection cycle closes). A pattern of persistent Phase II deficiencies can result in more intensive oversight, including an unannounced inspection.

PT requirements under CAP and CLIA

Both frameworks impose proficiency testing requirements for regulated analytes, and both require that PT specimens be handled identically to patient specimens. Under CLIA, failure to participate in required PT, or deliberately circumventing PT requirements (including sending specimens to reference laboratories or consulting with other labs before submission), is a serious violation that can result in certificate suspension or revocation. CAP PT requirements align with CLIA for regulated analytes and extend the expectation of external quality assessment to additional disciplines through CAP's own survey portfolio.

CLIA and the Canadian context

Canada has no direct federal equivalent to CLIA. Laboratory regulation in Canada is a provincial responsibility, with each province maintaining its own licensing and quality framework. However, CAP accreditation is widely sought by Canadian laboratories — particularly reference labs, academic medical centre labs, and facilities with US clients or research partners — because it provides internationally recognized quality credentials and is accepted by most provincial accreditation programs as evidence of quality compliance.

For Canadian laboratories operating under CPSA in Alberta, DAP in British Columbia, or OLA/IQMH in Ontario, CAP accreditation provides a strong foundation. Its checklist requirements map well to the quality management elements assessed under provincial frameworks, and its PT programs are accepted for fulfilling provincial EQA requirements. Many large Canadian labs maintain both CAP accreditation and provincial compliance in parallel.

See how this applies to your lab

Our team works directly with accredited laboratories on quality systems, technology platforms, and accreditation readiness.